{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:10:01Z","timestamp":1780607401931,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00066-018-1390-3","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T15:40:57Z","timestamp":1540827657000},"page":"236-245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Fractionated stereotactic radiation therapy for adrenal metastases: contributing to local tumor control with low toxicity","Fraktionierte stereotaktische Strahlentherapie bei Nebennierenmetastasen: Beitrag zur lokalen Tumorkontrolle mit geringer Toxizit\u00e4t"],"prefix":"10.1007","volume":"195","author":[{"given":"Kim","family":"Burjakow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Fietkau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Putz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Achterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Lettmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Knippen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,29]]},"reference":[{"issue":"1","key":"1390_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/1097-0142(19900101)65:1<177::AID-CNCR2820650134>3.0.CO;2-8","volume":"65","author":"AWC Kung","year":"1990","unstructured":"Kung AWC, Pun KK, Lam K, Wang C, Leung CY (1990) Addisonian Crisis as Presenting Feature in Malignancies. Cancer 65(1):177\u2013179. \n                    https:\/\/doi.org\/10.1002\/1097-0142(19900101)65:1","journal-title":"Cancer"},{"issue":"1","key":"1390_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1046\/j.0300-0664.2001.01435.x","volume":"56","author":"KY Lam","year":"2002","unstructured":"Lam KY, Lo CY (2002) Metastatic tumours of the adrenal glands: a\u00a030-year experience in a\u00a0teaching hospital. Clin Endocrinol 56(1):95\u2013101. \n                    https:\/\/doi.org\/10.1046\/j.0300-0664.2001.01435.x","journal-title":"Clin Endocrinol"},{"issue":"5","key":"1390_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1001\/jama.1982.03330050063034","volume":"248","author":"P Twomey","year":"1982","unstructured":"Twomey P, Montgomery C, Clark O (1982) Successful treatment of adrenal metastases from large-cell carcinoma of the lung. J\u00a0Am Med Assoc 248(5):581\u2013583. \n                    https:\/\/doi.org\/10.1001\/jama.248.5.581","journal-title":"J Am Med Assoc"},{"issue":"4","key":"1390_CR4","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/bjs.1800830432","volume":"83","author":"CY Lo","year":"1996","unstructured":"Lo CY, vanHeerden JA, Soreide JA, Grant CS, Thompson GB, Lloyd RV, Harmsen WS (1996) Adrenalectomy for metastatic disease to the adrenal glands. Brit J Surg 83(4):528\u2013531. \n                    https:\/\/doi.org\/10.1002\/bjs.1800830432","journal-title":"Brit J Surg"},{"issue":"8","key":"1390_CR5","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s00066-017-1120-2","volume":"193","author":"K Mohnike","year":"2017","unstructured":"Mohnike K, Neumann K, Hass P, Seidensticker M, Seidensticker R, Pech M, Klose S, Streitparth T, Garlipp B, Benckert C, Wendler JJ, Liehr UB, Schostak M, Goppner D, Gademann G, Ricke J (2017) Radioablation of adrenal gland malignomas with interstitial high-dose-rate brachytherapy : Efficacy and outcome. Strahlenther Onkol 193(8):612\u2013619. \n                    https:\/\/doi.org\/10.1007\/s00066-017-1120-2","journal-title":"Strahlenther Onkol"},{"issue":"6","key":"1390_CR6","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/1097-0142(19900315)65:6<1318::AID-CNCR2820650611>3.0.CO;2-H","volume":"65","author":"EM Soffen","year":"1990","unstructured":"Soffen EM, Solin LJ, Rubenstein JH, Hanks GE (1990) Palliative radiotherapy for symptomatic adrenal metastases. Cancer 65(6):1318\u20131320","journal-title":"Cancer"},{"issue":"6","key":"1390_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0936-6555(96)80087-2","volume":"8","author":"S Short","year":"1996","unstructured":"Short S, Chaturvedi A, Leslie MD (1996) Palliation of symptomatic adrenal gland metastases by radiotherapy. Clin Oncol 8(6):387\u2013389","journal-title":"Clin. Oncol."},{"issue":"3","key":"1390_CR8","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.radonc.2008.03.013","volume":"87","author":"N Katoh","year":"2008","unstructured":"Katoh N, Onimaru R, Sakuhara Y, Abo D, Shimizu S, Taguchi H, Watanabe Y, Shinohara N, Ishikawa M, Shirato H (2008) Real-time tumor-tracking radiotherapy for adrenal tumors. Radiother Oncol 87(3):418\u2013424. \n                    https:\/\/doi.org\/10.1016\/j.radonc.2008.03.013","journal-title":"Radiother Oncol"},{"issue":"6","key":"1390_CR9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00066-017-1099-8","volume":"193","author":"E Gkika","year":"2017","unstructured":"Gkika E, Adebahr S, Kirste S, Schimek-Jasch T, Wiehle R, Claus R, Wittel U, Nestle U, Baltas D, Grosu AL, Brunner TB (2017) Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT. Strahlenther Onkol 193(6):433\u2013443. \n                    https:\/\/doi.org\/10.1007\/s00066-017-1099-8","journal-title":"Strahlenther Onkol"},{"issue":"12","key":"1390_CR10","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s00066-016-1057-x","volume":"192","author":"TB Brunner","year":"2016","unstructured":"Brunner TB, Nestle U, Adebahr S, Gkika E, Wiehle R, Baltas D, Grosu AL (2016) Simultaneous integrated protection : A new concept for high-precision radiation therapy. Strahlenther Onkol 192(12):886\u2013894. \n                    https:\/\/doi.org\/10.1007\/s00066-016-1057-x","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"1390_CR11","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1097\/JTO.0b013e318262caf6","volume":"201","author":"D Ruysscher De","year":"1555","unstructured":"De Ruysscher D, Wanders R, van Baardwijk A, Dingemans AM, Reymen B, Houben R, Bootsma G, Pitz C, van Eijsden L, Geraedts W, Baumert BG, Lambin P (1555) Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a\u00a0prospective phase II trial (Nct01282450). J\u00a0Thorac Oncol 201(2):1547. \n                    https:\/\/doi.org\/10.1097\/JTO.0b013e318262caf6","journal-title":"J Thorac Oncol"},{"issue":"12","key":"1390_CR12","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","volume":"17","author":"DR Gomez","year":"2016","unstructured":"Gomez DR, Blumenschein GR Jr., Lee JJ, Hernandez M, Ye R, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Gibbons DL, Karam JA, Kavanagh BD, Tang C, Komaki R, Louie AV, Palma DA, Tsao AS, Sepesi B, William WN, Zhang J, Shi Q, Wang XS, Swisher SG, Heymach JV (2016) Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a\u00a0multicentre, randomised, controlled, phase 2 study. Lancet Oncol 17(12):1672\u20131682. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(16)30532-0","journal-title":"Lancet Oncol"},{"issue":"1","key":"1390_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00066-013-0450-y","volume":"190","author":"M Guckenberger","year":"2014","unstructured":"Guckenberger M, Andratschke N, Alheit H, Holy R, Moustakis C, Nestle U, Sauer O, Deutschen Gesellschaft fur R (2014) Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer. Strahlenther Onkol 190(1):26\u201333. \n                    https:\/\/doi.org\/10.1007\/s00066-013-0450-y","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"1390_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijrobp.2008.10.079","volume":"75","author":"S Chawla","year":"2009","unstructured":"Chawla S, Chen Y, Katz AW, Muhs AG, Philip A, Okunieff P, Milano MT (2009) Stereotactic body radiotherapy for treatment of adrenal metastases. Int J Radiat Oncol Biol Phys 75(1):71\u201375. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2008.10.079","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1390_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00066-011-2192-z","volume":"187","author":"R Holy","year":"2011","unstructured":"Holy R, Piroth M, Pinkawa M, Eble MJ (2011) Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer. Strahlenther Onkol 187(4):245\u2013251. \n                    https:\/\/doi.org\/10.1007\/s00066-011-2192-z","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"1390_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/COC.0b013e3182569189","volume":"36","author":"KA Ahmed","year":"2013","unstructured":"Ahmed KA, Barney BM, Macdonald OK, Miller RC, Garces YI, Laack NN, Haddock MG, Foote RL, Olivier KR (2013) Stereotactic body radiotherapy in the treatment of adrenal metastases. Am J Clin Oncol 36(5):509\u2013513. \n                    https:\/\/doi.org\/10.1097\/COC.0b013e3182569189","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"1390_CR17","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.ijrobp.2010.11.060","volume":"82","author":"F Casamassima","year":"2012","unstructured":"Casamassima F, Livi L, Masciullo S, Menichelli C, Masi L, Meattini I, Bonucci I, Agresti B, Simontacchi G, Doro R (2012) Stereotactic radiotherapy for adrenal gland metastases: university of Florence experience. Int J Radiat Oncol Biol Phys 82(2):919\u2013923. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2010.11.060","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1390_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fonc.2015.00185","volume":"5","author":"A Desai","year":"2015","unstructured":"Desai A, Rai H, Haas J, Witten M, Blacksburg S, Schneider JG (2015) A retrospective review of Cyberknife stereotactic body radiotherapy for adrenal tumors (primary and metastatic): Winthrop university hospital experience. Front Oncol 5:185. \n                    https:\/\/doi.org\/10.3389\/fonc.2015.00185","journal-title":"Front Oncol"},{"issue":"3","key":"1390_CR19","doi-asserted-by":"publisher","first-page":"e1120","DOI":"10.7759\/cureus.1120","volume":"9","author":"A Haidenberger","year":"2017","unstructured":"Haidenberger A, Heidorn SC, Kremer N, Muacevic A, Furweger C (2017) Robotic radiosurgery for adrenal gland metastases. Cureus 9(3):e1120. \n                    https:\/\/doi.org\/10.7759\/cureus.1120","journal-title":"Cureus"},{"issue":"3","key":"1390_CR20","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1016\/j.prro.2016.09.005","volume":"7","author":"WW Chance","year":"2017","unstructured":"Chance WW, Nguyen QN, Mehran R, Welsh JW, Gomez DR, Balter P, Komaki R, Liao Z, Chang JY (2017) Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity. Pract Radiat Oncol 7(3):e195\u2013e203. \n                    https:\/\/doi.org\/10.1016\/j.prro.2016.09.005","journal-title":"Pract Radiat Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-018-1390-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-018-1390-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-018-1390-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:09:48Z","timestamp":1572307788000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-018-1390-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,29]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1390"],"URL":"https:\/\/doi.org\/10.1007\/s00066-018-1390-3","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,29]]},"assertion":[{"value":"16 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"K.\u00a0Burjakow, R.\u00a0Fietkau, F.\u00a0Putz, N.\u00a0Achterberg, S.\u00a0Lettmaier, and S.\u00a0Knippen declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments. For this retrospective study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}